Sygnature Discovery
Nottingham
About Sygnature Discovery
Sygnature Discovery is an independent provider of integrated drug discovery resource and expertise. It undertakes hit identification, hit-to-lead and lead optimization projects, and complete drug discovery programs. Core capabilities include medicinal chemistry, in vitro bioscience, computational sciences and informatics, DMPK/physical sciences, and project management. Sygnature operates from state of the art facilities in Nottingham and employs over 200 staff, most of whom are PhD scientists.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Funding stage: Private Equity
- Last round: Secondary Market (Jun 2021)
- Website: sygnaturediscovery.com
- Phone: +441159415401
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/sygnature-discovery-2296111 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.